Noxopharm Limited (NOX.AX)
AUD 0.07
(0.0%)
AUD 0.07
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | -2.35 Million AUD | 0.0% |
| 2023 | - AUD | -100.0% |
| 2022 | 1.14 Million AUD | 268.04% |
| 2021 | 311.51 Thousand AUD | -40.01% |
| 2020 | 519.22 Thousand AUD | -25.44% |
| 2019 | 696.4 Thousand AUD | -45.12% |
| 2018 | 1.26 Million AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | - AUD | 0.0% |
| 2024 Q4 | -2.35 Million AUD | 0.0% |
| 2024 FY | - AUD | 0.0% |
| 2023 FY | - AUD | -100.0% |
| 2023 Q2 | 1.05 Million AUD | 0.0% |
| 2023 Q4 | - AUD | 0.0% |
| 2022 Q2 | 670.7 Thousand AUD | 0.0% |
| 2022 FY | 1.14 Million AUD | 268.04% |
| 2022 Q4 | 1.14 Million AUD | 0.0% |
| 2021 Q2 | 396.61 Thousand AUD | 0.0% |
| 2021 FY | 311.51 Thousand AUD | -40.01% |
| 2021 Q4 | 311.51 Thousand AUD | 0.0% |
| 2020 FY | 519.22 Thousand AUD | -25.44% |
| 2020 Q4 | 519.22 Thousand AUD | 0.0% |
| 2020 Q2 | 574.94 Thousand AUD | 0.0% |
| 2019 Q2 | 885.76 Thousand AUD | 0.0% |
| 2019 Q4 | 696.4 Thousand AUD | 0.0% |
| 2019 FY | 696.4 Thousand AUD | -45.12% |
| 2018 Q4 | 1.26 Million AUD | 0.0% |
| 2018 FY | 1.26 Million AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AdAlta Limited | -1.67 Million AUD | -40.471% |
| Biome Australia Limited | 1.88 Million AUD | 224.922% |
| Radiopharm Theranostics Limited | -987.41 Thousand AUD | -138.932% |
| Biotron Limited | - AUD | Infinity% |
| Acrux Limited | 147 Thousand AUD | 1704.926% |
| Alterity Therapeutics Limited | 1.00 AUD | 235924200.0% |
| Botanix Pharmaceuticals Limited | 1.2 Million AUD | 295.08% |
| BTC Health Limited | - AUD | Infinity% |
| Chimeric Therapeutics Limited | - AUD | Infinity% |
| CSL Limited | 8.93 Billion AUD | 100.026% |
| Clarity Pharmaceuticals Ltd | - AUD | Infinity% |
| Clinuvel Pharmaceuticals Limited | 10.62 Million AUD | 122.201% |
| Immutep Limited | 2.00 AUD | 117962150.0% |
| Memphasys Limited | 164.76 Thousand AUD | 1531.917% |
| Neuren Pharmaceuticals Limited | - AUD | Infinity% |
| Prescient Therapeutics Limited | - AUD | Infinity% |
| Race Oncology Limited | 16.4 Thousand AUD | 14484.739% |
| Starpharma Holdings Limited | 2.4 Million AUD | 197.975% |
| Tissue Repair Ltd | 214.72 Thousand AUD | 1198.742% |
| EZZ Life Science Holdings Limited | 1.4 Million AUD | 268.373% |
| Anatara Lifesciences Ltd | -671.09 Thousand AUD | -251.553% |
| Bio-Gene Technology Limited | - AUD | Infinity% |
| Zelira Therapeutics Limited | 1.25 Million AUD | 288.391% |
| Patrys Limited | - AUD | Infinity% |
| Orthocell Limited | 1.17 Million AUD | 300.507% |
| Imugene Limited | - AUD | Infinity% |
| PYC Therapeutics Limited | -17.99 Million AUD | 86.89% |
| Proteomics International Laboratories Limited | - AUD | Infinity% |
| Cynata Therapeutics Limited | 108.2 Thousand AUD | 2280.364% |
| Arovella Therapeutics Limited | - AUD | Infinity% |
| Nanollose Limited | - AUD | Infinity% |
| Invex Therapeutics Ltd | -94.98 Thousand AUD | -2383.856% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | Infinity% |
| Amplia Therapeutics Limited | - AUD | Infinity% |
| Island Pharmaceuticals Limited | -877.24 Thousand AUD | -168.939% |
| Nyrada Inc. | - AUD | Infinity% |
| Telix Pharmaceuticals Limited | 17.31 Million AUD | 113.629% |
| Dimerix Limited | - AUD | Infinity% |
| PharmAust Limited | - AUD | Infinity% |
| Hexima Limited | - AUD | Infinity% |
| AnteoTech Limited | 221.85 Thousand AUD | 1163.406% |
| Paradigm Biopharmaceuticals Limited | - AUD | Infinity% |
| Recce Pharmaceuticals Ltd | - AUD | Infinity% |
| Avecho Biotechnology Limited | 97.11 Thousand AUD | 2529.277% |
| Actinogen Medical Limited | 108.82 Thousand AUD | 2267.842% |
| Immuron Limited | 1.58 Million AUD | 248.885% |
| Argenica Therapeutics Limited | - AUD | Infinity% |